Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Dec. 26, 2020	Dec. 28, 2019
Cash flows from operating activities
Net income	$ 51,013	$ 52,162
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	8,994	9,826
Amortization of intangible assets	4,082	4,069
Amortization of deferred financing fees	380	384
Fair market value adjustment for asset classified as held for sale		986
Equity-based compensation	4,625	6,168
Deferred taxes	3,251	4,222
(Gain) loss on disposal of property, plant, and equipment	(75)	126
Foreign currency transaction gain	(421)	(93)
Change in assets and liabilities:
Accounts receivable	4,577	15,441
Inventories	(3,388)	14,980
Prepaids and other assets	(2,239)	(6,199)
Accounts payable	(284)	(16,130)
Accrued expenses and other liabilities	33,301	(12,865)
Net cash provided by operating activities	103,816	73,077
Cash flows from investing activities
Additions to property, plant, and equipment	(4,235)	(12,110)
Proceeds from maturity of company owned life insurance policy	1,186
Proceeds from disposal of property, plant, and equipment	1,836	44
Proceeds from sale of held for sale asset		1,100
Net cash used in investing activities	(1,213)	(10,966)
Cash flows from financing activities
Changes in floor plan financing, net	(8,318)	(946)
Payments on revolving debt facility	(38,000)	(15,000)
Stock option exercises	67	109
Tax payments for equity-based compensation	(1,687)	(2,131)
Net cash used in financing activities	(47,938)	(17,968)
Effect of exchange rate changes on cash and cash equivalents	2,940	510
Net increase in cash and cash equivalents	57,605	44,653
Cash and cash equivalents at beginning of period	209,455	126,634
Cash and cash equivalents at end of period	$ 267,060	$ 171,287